Quell® Wearable Relief Technology Selected as Finalist in the Last Gadget Standing Competition at CES 2016

Press Releases

Quell® Wearable Relief Technology Selected as Finalist in the Last Gadget Standing Competition at CES 2016

WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell has been selected as one of 10 finalists in the Last Gadget Standing event at CES 2016. Now in its 15th year, Last Gadget Standing is one of the best loved and longest running events at the International Consumer Electronics Show (CES).

"We are proud that Quell was selected as one of ten finalists by a panel of judges comprised of journalists and industry analysts who are working on the leading edge of consumer technology, digital health and mobile," said Frank McGillin, Sr. VP and General Manager of NeuroMetrix, Inc. "Quell is a great example of how wearable technology and innovation can make a meaningful difference in people's lives."

The event is hosted by David Pogue, founder of Yahoo Tech, a monthly columnist for Scientific American, host of science shows on PBS's "NOVA" and a correspondent for "CBS Sunday Morning". Mr. Pogue was previously the personal-technology columnist for the New York Times and has authored dozens of books. He's been profiled on "48 Hours" and "60 Minutes".

Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix's patented neurostimulation technology to provide pain relief. In a recent clinical study, Quell improved chronic pain and overall health in 81% of participants. Quell is currently available through select healthcare professionals, retailers, and online at www.QuellRelief.com.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.

News Provided by Acquire Media